ǰÑÔ
ÉöСÇò¼²²¡(glomerular diseases)ÊDz¡Òò¡¢·¢²¡»úÖÆ¡¢ÁÙ´²ÌåÏÖ¡¢²¡Àí¸Ä±ä¡¢²¡³ÌºÍÔ¤ºó²»¾¡ÏàͬµÄÖ÷ÒªÀÛ¼°Ë«ÉöÉöСÇòµÄÒ»×é¼²²¡£¬¿É·ÖΪԷ¢ÐÔ¡¢¼Ì·¢ÐÔºÍÒÅ´«ÐÔ¡£´ó¶¼ÉöСÇòÉöÑ×ÊÇÃâÒ߽鵼ÐÔÑ×Ö¢¼²²¡¡£Ò»Ñùƽ³£ÒÔΪ£¬ÃâÒß»úÖÆÊÇÉöСÇò²¡µÄʼ·¢»úÖÆ£¬ÉöСÇò¼²²¡¶¯ÎïÄ£×ÓÔÚ̽ÌÖ·¢²¡»úÖÆ¡¢²¡ÀíÀú³ÌÒÔ¼°ÁÙ´²ÖÎÁƵȷ½ÃæÊ©Õ¹Ö÷Òª×÷Óᣱ¾½ÚÖ÷ÒªÏÈÈÝÁËϵĤÔöÖ³ÐÔÉöСÇòÉöÑס¢Thy1ϵĤÔöÉúÐÔÉöÑס¢Ï¸Ð¡²¡±äÐÍÉö²¡¡¢IgAÉö²¡ÒÔ¼°ÉöСÇòÓ²»¯ÐÔÉö²¡¶¯ÎïÄ£×ӵĽ¨ÉèÒªÁìºÍÌØµã¡£
ϵĤÔöÖ³ÐÔÉöСÇòÉöÑ×(mesangial proliferative glomerulonephritis)ÊÇÆ¾Ö¤¹â¾µËù¼ûµÄÒ»ÖÖ²¡ÀíÐÎ̬ѧÕï¶ÏµÄÉöÑ×£¬ÊÇÒ»×éÒÔÃÖÂþÐÔÉöСÇòϵĤϸ°ûÔöÉú¼°²î±ðˮƽϵĤ»ùÖÊÔö¶àΪÖ÷ÒªÌØÕ÷µÄÉöСÇò¼²²¡¡£ÁÙ´²ÉÏÌåÏÖΪÒþÄäÐÔÉöСÇò¼²²¡¡¢ÂýÐÔÉöСÇòÑ×¼°Ô·¢ÐÔÉö²¡×ÛºÏÕ÷¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î´óÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
´ó³¦°£Ï£¾ú¡¢Å£ÑªÇåÇåÂѰ×(bovine serum albumin,BSA)¡¢ÆÏÌÑÇò¾ú³¦¶¾ËØB(staphylococcal enterotoxin B,SEB)¡¢ÖзÖ×Ó¿¹ÔÂÑÇåÂѰ׵ȿ¹ÔÍŽ᲻ÍêÈ«»òÍêÈ«¸¥ÊÏ×ô¼ÁÒýÆð賦ð¤Ä¤ÃâÒߣ¬µ¼Ö´ó×ÚµÄÃâÒ߸´ºÏÎï³Á»ý£¬´Ó¶øÓÕ·¢ÒÔÉöСÇòϵĤÔöÉúΪÖ÷Òª²¡Àí¸Ä±äµÄÉö²¡Ä£×Ó¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
1.ʵÑéÀú³Ì Ñ¡ÓÃ6ÖÜÁäÐÛÐÔSprague Dawley´óÊó£¨ÌåÖØ160~200g)£¬´ÓʵÑéµÄµÚ1ÌìÆðÒÔº¬20mgµÄBSAË®ÈÜÒº£¬¸ôÈÕ¹à裬¹²14ÖÜ¡£ÆäÖУ¬µÚ1ÌìÆ¤ÏÂ×¢ÉäÍêÈ«¸¥ÊÏ×ô¼Á0.2ml£¨º¬BSA 2mg),µÚ8Ìì¾Æ¤ÏÂ×¢Éä²»ÍêÈ«¸¥ÊÏÊÔ¼Á0.2ml£¨º¬BSA 2mg)£¬Í¬Ê±¾²Âö×¢ÉäSEB(0.4mg/kg)£¬µÚ15ÌìÔÙ¾²Âö×¢ÉäSEB(0.4mg/kg)¡£
2.Ö¸±êÊÓ²ì »®·ÖÔÚµÚ10ÖÜ¡¢12ÖÜ¡¢14ÖܾÙÐÐÄòºìϸ°û¾µ¼ì¡¢ÄòÂѰ׼ì²âÒÔ¼°24СʱÄòÂѰ׶¨Á¿¡£ÊµÑéǰ¼°Õý·¨Ê±»®·Ö¼ì²âѪÇåÄòËØµª(blood urea nitrogen,BUN)¡¢¼¡ôû(creatinine,Cr)¡¢×ܵ¨¹Ì´¼¡¢×ÜÂѰ׼°Ñ»·ÃâÒ߸´ºÏÎïˮƽ¡£Í¬Ê±¶ÔÉöÔಡÀíÇÐÆ¬¾ÙÐÐH&E¡¢PAS¡¢PASM¼°MassonȾɫ£¬¹â¾µÊÓ²ìÉöСÇòµÄ²¡Àíת±ä£¬²¢¾ÙÐÐÉöСÇòϵĤϸ°û¼ÆÊýºÍÉöСÇòϵĤÔöÉúˮƽÆÀ¼Û¡£Åжϱê×¼£ºÇá¶ÈΪϵĤÇá¶ÈÔöÉú£¬Ã«Ï¸Ñª¹ÜδÊÜѹ»òÇá¶ÈÊÜѹ£»ÖضÈÎªÏµÄ¤ÖØ¶ÈÔöÉú£¬ÒÔϵĤ»ùÖÊΪÖ÷£¬Ã«Ï¸Ñª¹ÜÑÏÖØÊÜѹ£»ÖжÈΪϵĤÔöÉúˮƽ½éÓÚÁ½ÕßÖ®¼ä¡£×îºóʹÓÃ͸Éäµç¾µÊÓ²ìÉöÔàµÄ³¬Î¢½á¹¹¡£
¡¾Ä£×ÓÌØµã¡¿£º
1.ʵÑé10ÖÜ´óÊó·ºÆðÂѰ×Äò£¬24СʱÄòÂѰ×Ëæ×Åʱ¼äµÄÑÓÉì¶øÔöÌí£¬°éÓÐѪÇåCrµÄÏÔ×ÅÉý¸ß¡£
2.ÉöϵĤ»ùÖÊÖжÈÔöÉú£¬ÉöСÇòϸ°ûÊýÇá¶ÈÔö¶à£¬ÉöС¹Ü¼äÖÊÎÞÏÔ×Åת±ä£¬ÉöСÇòÏµÄ¤ÇøÓдó×ÚIgAÓ«¹â³Á»ý¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ϵĤÔöÖ³ÐÔÉöÑ×ÊÇÈËÀàÔ·¢ÐÔÉöСÇò¼²²¡×î³£¼ûµÄ²¡ÀíÀàÐÍ£¬Ô¼Õ¼Õû¸öÉöÔ༲²¡µÄ50%~60%¡£±¾Ä£×Ó×ÛºÏÓ¦ÓÃBSA¹àθ¡¢¸¥ÊÏ×ô¼ÁƤÏÂ×¢Éä¡¢SEB¾²Âö×¢É䣬½¨ÉèÁËÒ»ÖÖ²¡±äÎȹ̵ĴóÊóϵĤÔöÖ³ÐÍÉöСÇòÉöÑ×Ä£×Ó£¬¿ÉÓÃÓÚÑо¿ÏµÄ¤ÔöÖ³ÐÍÉöСÇòÉöÑ׵ķ¢²¡»úÖÆÒÔ¼°Î¸³¦µÀð¤Ä¤ÃâÒßÔÚ·¢²¡Àú³ÌÖеÄ×÷Óá£
²Î¿¼ÎÄÏ×£º
1.ÌÀÓ±£¬Â¦Ì½Ææ£¬³É²ÊÁª£¬µÈʵÑéÐÔIgAÉö²¡Ä£×ÓµÄˢУ®ÖÐɽ´óѧѧ±¨£¨Ò½Ñ§¿ÆÑ§°æ£©£¬2006,27 (2): 184-187
2.Î⺺Àû£¬Ëïΰ£®°¢Èá±ÈÐǽ¨ÉèÉö²¡Ä£×ӵįÀ¼Û£®ÖйúÖÐÒ½¼±Ö¢£¬2010,19 (2):290-191
3.ÕÅÀö·Ò£¬»ÆÎÄÕþ£¬ÖìС馣¬µÈ£®°¢Ã¹ËØÉö²¡ÉöСÇòÓ²»¯¶¯ÎïÄ£×ÓµÄÑо¿. ÖйúÖÐÎ÷ҽ͎áÉö²¡ÔÓÖ¾£¬2005,6 (4):195-199
4.Õſ˷ǣ¬ÕÅÁÁ£¬ÎâÐÛ·É£¬µÈ£®´óÊó¿¹Thy1ϵĤÔöÉúÐÔÉöСÇòÉöÑ×Ä£×Ó·¢²¡»úÖÆÌ½ÌÖ£®ËÄ´¨´óѧѧ±¨£¨Ò½Ñ§°æ£©£¬ 2004,35 (2): 188-190
5.³Â¹ãƽ£¬¹ù¹§ÒÀ£¬ÕÅÔ¶𣬵ȣ®´óÊóThy1¿¹ÑªÇåÖÆ±¸¼°ÏµÄ¤ÔöÉúÐÔÉöÑ×Ä£×ӵĽ¨É裮ÁÙ´²ÓëʵÑ鲡ÀíѧÔÓÖ¾£¬1996, 12 (3):241-243
6.»ÆÊ¤£¬ËïÁÖ£¬Ò¶Èθߣ¬µÈ£®Á½ÖÖϵĤÔöÖ³ÐÔÉöÑ×´óÊóÄ£×ӵĽ¨Éè½ÏÁ¿£®ÖйúʵÑ鶯Îïѧ±¨£¬2002, 10 (4): 236-238
7.Marquina R, Dfez MA,López-Hoyos M,el al. Inhibition of B cell death causes the development of an lgA nephropathy in(New Zealand white x C578L/6)F(l)-bel-2 transgenic mice. J lmmunol,2004,172(11):7177-7185
8.Zhang Z, Kundu GC, Yuan CJ, el al. Severe fibroneclindeposit renal glomerular disease in mice lacking uteroglobin. Science, 1997,276(5317): 1408-1412